JAZZ vs NJR · P/E 1988, rev $2.28B vs P/E 16, rev $1.35B
Jazz Pharmaceuticals PLC (JAZZ) versus NewJersey Resources Corporation (NJR) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
NewJersey Resources Corporation (NJR) is a utilities - regulated gas company listed on NYSE.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported NJR revenue for 2025-09-30 was $1.35B. Net income was $335.6M. NJR currently screens at market cap $5.58B and trailing P/E 16.4.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. NJR currently screens at market cap $5.58B and trailing P/E 16.4.
Not investment advice. Open the JAZZ and NJR stock pages for the full models.
Not investment advice.